You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BLU 667

Showing 1 - 25 of 45
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, Medullary Thyroid Cancer Trial (pralsetinib (BLU-667))

Approved for marketing
  • Non-Small Cell Lung Cancer
  • Medullary Thyroid Cancer
  • pralsetinib (BLU-667)
  • (no location specified)
Aug 9, 2021

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +65 more
Nov 10, 2022

Pralsetinib to Best Available Therapy in RET-Fusion Positive

Enrolling by invitation
  • RET-fusion Non Small Cell Lung Cancer
  • +16 more
    • New York, New York
    • +2 more
    Aug 9, 2021

    Advanced Systemic Mastocytosis Trial (BLU-263, Azacitidine)

    Not yet recruiting
    • Advanced Systemic Mastocytosis
    • (no location specified)
    Nov 2, 2022

    Refractory Chronic Cough Trial in United States (BLU-5937, Placebo)

    Recruiting
    • Refractory Chronic Cough
    • Gulf Shores, Alabama
    • +30 more
    Jan 23, 2023

    Healthy Trial in Québec (Camlipixant + Gemfibrozil, Dabigatran etexilate + camlipixant)

    Not yet recruiting
    • Healthy
    • Camlipixant + Gemfibrozil
    • Dabigatran etexilate + camlipixant
    • Québec, Quebec, Canada
      Syneos Health
    Jul 17, 2023

    Refractory Chronic Cough Trial in United States (BLU-5937, Placebo)

    Recruiting
    • Refractory Chronic Cough
    • Scottsdale, Arizona
    • +6 more
    Oct 31, 2022

    Healthy Trial in Québec (Camlipixant + Rifampin, Camlipixant + Rabeprazole)

    Not yet recruiting
    • Healthy
    • Camlipixant + Rifampin
    • Camlipixant + Rabeprazole
    • Québec, Quebec, Canada
      Syneos Health
    Jun 2, 2023

    Lung Tumor Malignant, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-451)

    Recruiting
    • Lung Neoplasm Malignant
    • +18 more
    • Fairfax, Virginia
      New Experimental Therapeutics of Virginia (NEXT Oncology)
    Mar 29, 2022

    Lung Tumors, NSCLC, Respiratory Tract Tumors Trial in Worldwide (BLU-945, osimertinib)

    Recruiting
    • Lung Neoplasms
    • +23 more
    • La Jolla, California
    • +35 more
    Oct 6, 2022

    GIST Trial in Worldwide (avapritinib, regorafenib)

    Completed
    Has Results
    • GIST
    • Phoenix, Arizona
    • +113 more
    Sep 9, 2022

    Healthy Trial in Nottingham (BLU-5937 IR, BLU-5937 ER)

    Recruiting
    • Healthy
    • BLU-5937 IR
    • BLU-5937 ER
    • Nottingham, England, United Kingdom
      Quotient Sciences
    Oct 4, 2022

    Indolent Systemic Mastocytosis, Monoclonal Mast Cell Activation Syndrome Trial in Worldwide (BLU-263, Placebo)

    Recruiting
    • Indolent Systemic Mastocytosis
    • Monoclonal Mast Cell Activation Syndrome
    • Palo Alto, California
    • +33 more
    Jul 27, 2022

    Aggressive Systemic Mastocytosis, Systemic Mastocytosis-associated Hematologic Non-mast Cell Disease, Mast Cell Leukemia Trial

    Completed
    • Aggressive Systemic Mastocytosis
    • +3 more
    • Stanford, California
    • +10 more
    Jan 12, 2023

    ER+ Breast Cancer, CCNE1 Amplification, HER2-negative Breast Cancer Trial in United States (BLU-222, Carboplatin, Ribociclib)

    Recruiting
    • ER+ Breast Cancer
    • +8 more
    • Sarasota, Florida
    • +3 more
    Jun 8, 2022

    Healthy Volunteers Trial in Burbank (Combustible Cigarette, blu Disposable A, blu Disposable B)

    Active, not recruiting
    • Healthy Volunteers
    • Combustible Cigarette
    • +5 more
    • Burbank, California
      LA Clinical Trials, LLC
    Jul 11, 2022

    Lung Tumor, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-701, osimertinib, carboplatin)

    Recruiting
    • Lung Neoplasm
    • +26 more
    • Boston, Massachusetts
    • +6 more
    Jun 23, 2022

    RibFix Blu Thoracic Fixation System Versus Non-surgical

    Recruiting
    • Rib; Fracture
    • Non surgical and Surgical
    • Bedford Park, South Australia, Australia
    • +3 more
    Feb 3, 2022

    Healthy Trial in Nottingham ([14C]-BLU-5937)

    Completed
    • Healthy
    • Nottingham, Ruddington, United Kingdom
      Quotient Sciences
    Feb 11, 2022

    Avapritinib Versus Best Available Therapy in Patients With AdvSM

    Completed
    • Advanced Systemic Mastocytosis
    • +3 more
      • Palo Alto, California
      • +5 more
      Dec 17, 2021

      Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Systemic Mastocytosis With an Associated Hematologic Tumor

      Active, not recruiting
      • Advanced Systemic Mastocytosis
      • +3 more
      • Stanford, California
      • +31 more
      Mar 25, 2022

      Refractory Chronic Cough Trial in Worldwide (BLU-5937, Placebo)

      Completed
      • Refractory Chronic Cough
      • Peoria, Arizona
      • +115 more
      Dec 10, 2021

      Chronic Pruritus, Atopic Dermatitis Trial in Canada, United States (BLU-5937, Placebo)

      Completed
      • Chronic Pruritus
      • Atopic Dermatitis
      • Phoenix, Arizona
      • +32 more
      Nov 30, 2021

      Gastrointestinal Stromal Tumors (GIST), Other Relapsed or Refractory Solid Tumors Trial in Worldwide (Avapritinib)

      Completed
      Has Results
      • Gastrointestinal Stromal Tumors (GIST)
      • Other Relapsed or Refractory Solid Tumors
      • Scottsdale, Arizona
      • +18 more
      May 20, 2022

      Hepatocellular Carcinoma (HCC) Trial in Worldwide (Fisogatinib (BLU-554))

      Active, not recruiting
      • Hepatocellular Carcinoma (HCC)
      • Fisogatinib (BLU-554)
      • Rialto, California
      • +40 more
      Aug 12, 2022